Vote Scores

Home / Companies / Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. / 20 May 2024

Meeting · year to 30 June 202436 filers reporting

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.: meeting of 20 May 2024

Votes reported on Form N-PX, item by item

36 Form N-PX filers reported votes at the Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. meeting of 20 May 2024. Their records fall into 9 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 100.0% of reported votes for; no filer withheld from or voted against at least one nominee.

20 vote records from 7 filers. 0 of the 7 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management7 filers
2

DIRECTOR ELECTIONSSecurity holder

Director elections (nominees put forward by security holders)

2 nominees; 100.0% of reported votes for; no filer withheld from or voted against at least one nominee.

124 vote records from 29 filers. 0 of the 29 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management29 filers
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

72 vote records from 36 filers. 0 of the 36 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management36 filers100.0% for0.0% against0.0% against management2,571,421 reported shares
4

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

9 vote records from 6 filers. 0 of the 6 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management6 filers100.0% for0.0% against0.0% against management136,084 reported shares, counted once per item in this group
5

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

72 vote records from 36 filers. 0 of the 36 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management36 filers100.0% for0.0% against0.0% against management2,571,421 reported shares, counted once per item in this group
6

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

72 vote records from 36 filers. 0 of the 36 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management36 filers100.0% for0.0% against0.0% against management2,571,421 reported shares, counted once per item in this group
7

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

325 vote records from 36 filers. 0 of the 36 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management36 filers100.0% for0.0% against0.0% against management12,364,569 reported shares, counted once per item in this group
8

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

45 vote records from 6 filers. 0 of the 6 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management6 filers100.0% for0.0% against0.0% against management544,336 reported shares, counted once per item in this group
9

CORPORATE GOVERNANCESecurity holder

Amend Articles of Association and Rules and Procedures Regarding Meetings of Board of Directors

64 vote records from 29 filers. 0 of the 29 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management29 filers100.0% for0.0% against0.0% against management2,409,737 reported shares

How the largest families voted

Family1. Directors2. Directors3. Auditor9. Proposal
VanguardNo reportForForFor
BlackRock and iSharesNo reportForForFor
FidelityNo reportForForFor
DimensionalNo reportForForFor
State Street and SPDRNo reportForForFor
Franklin TempletonNo reportForForFor
EquitableNo reportForForFor
Charles SchwabForNo reportForNo report
Nuveen and TIAANo reportForForFor
ProShares and ProFundsNo reportForForFor
John Hancock and ManulifeForNo reportForNo report
Morgan Stanley, Eaton Vance and CalvertNo reportForForFor
J.P. MorganForNo reportForNo report
Jackson National fundsForNo reportForNo report
Northern Trust and FlexSharesNo reportForForFor
Lincoln FinancialNo reportForForFor
VoyaNo reportForForFor
BNY MellonNo reportForForFor
Pacific Life fundsNo reportForForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. meeting?

36 Form N-PX filers reported votes at the meeting of 20 May 2024. One proposal from security holders could be told apart in the filings. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. with a meeting date within three days of 20 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.